CAP Meeting Minutes
April 18 and May 24, 2006
April 18, 2006
May 24, 2006
April 18 Meeting
J. Brandl gave business update which included the site post Vitamin C closure, new product trial fermentation and a discussion of ultimate fate of Vitamin C building. J. Brandl reported that a decision on what will happen with the Vitamin C building would probably occur in June of 2006.
C. Meddaugh reviewed the last minutes (February 23, 2006). From last minutes, J. Brandl updated the CAP on the operation of the WWTP. Although waste and hydraulic levels are cut in half the treatment plant has continued to operate with no problems.
J. Brandl reported on a recent conversation with Dr. Stan Weiss in reference to the Asthma Study. Highlights of the conversation were as follows:
o A manuscript has been prepared and sent to the journal on the method used in the Asthma Study. Dr. Weiss could envision a series of articles.
Drs. Weiss and Weisel would like
to do an even more sophisticated data analysis using “econometrics” from the
o Dr. Weiss would discuss with Dr. Weisel the possibility of a statement from an AirQAP media event.
In discussing the above with the DSM CAP there was a consensus that one or both doctors should be at the media event to discuss what they can about the study. It was also suggested that the doctors be invited to the next DSM CAP meeting.
Dr. Zollinger pointed out that a “negative” conclusion from the Asthma Study is still worth reporting.
A review of chloroform data post Vitamin C closure should be scheduled for the next meeting.
DSM CAP members were invited to attend the AirQAP meeting of May 8, 2006 which would be a preparation meeting for the press briefing.
May 24, 2006 Meeting
The purpose of this meeting was to determine how and in what forum the Asthma Study should be released. From a May 8 meeting, of the AirQAP the AirQAP suggested that DSM CAP determine the next stops for the Asthma Study including a statement about the Asthma Study to be included in the AirQAP air monitoring press briefing.
D. Smyth stated he had attended the May 8 AirQAP meeting and has several issues with the draft DEP report.
o When comparing with others requires need to see data
o Need to say something about Hg sampling
o Impact of ozone
o Too much “sugar coating” – just report facts
o More emphasis on car pollutants.
J. Brandl will discuss above points with A. Tynan and AirQAP.
J. Brandl gave a brief update on the business including successful trials with a new fermentation product.
As noted earlier the main reason for this meeting was to discuss the next steps for the asthma study. After much debate a consensus was reached to have a separate press event. This will allow for adequate time for the doctors to discuss the report and answer questions without interfering with the AirQAP release of the monitoring results. TO make this happen, the following actions will be taken:
G. Meddaugh will send
o J. Brandl will discuss with M. Adams the possibility of using Steve Ross to help in the coordination and preparation of the press briefing.
o A. Tynan will make a OPRA request to NJDEP concerning the asthma study. The purpose in making the request is to determine if the DEP considers the report public and also to see if the report was reviewed by the Department of Health.
o S. Wilkins and D. Smyth will seek input from the Belvidere Environmental Commission on (??? Not sure what they are going to get input on).
o A meeting will be set up in June that the doctors could either attend or participate by phone conference. A tentative date has been selected of June 27.
Cc: M. Adams